KDM3A and Miyoshi myopathy: The MAF family of transcription factors, known driver oncogenes in MM44, 48, 49, may be associated with this aberrant KDM3A expression in a subset of MM, since KDM3A expression is modestly but significantly elevated in the subgroup of newly diagnosed MM patients with MAF translocations and high MAF expression (Supplementary Fig. 8a)50.